GLOW vs KLOW at a Glance
Both names are used loosely across the market, and ratios differ between suppliers. These are the exact contents of the Chainwell Peptide vials, confirmed on the certificate for each lot:
| Component | GLOW (70 mg) | KLOW (80 mg) | Main research area |
|---|---|---|---|
| GHK-Cu | 50 mg | 50 mg | Collagen synthesis, skin remodelling, copper delivery |
| BPC-157 | 10 mg | 10 mg | Tendon, gut and soft tissue repair models |
| TB-500 | 10 mg | 10 mg | Cell migration, angiogenesis, wound models |
| KPV | None | 10 mg | Inflammation, especially intestinal models |
| Total fill | 70 mg | 80 mg | |
| Cake colour | Blue | Blue | From the GHK-Cu copper |
GHK-Cu is the dominant component in both: about 71% of GLOW by mass and about 63% of KLOW. Both are really GHK-Cu vials with repair peptides added.
What Is the GLOW Stack Peptide?
The glow stack, also written glow stack.peptides or GLOW blend peptide in searches, is a pre-mixed, freeze-dried combination of GHK-Cu, BPC-157 and TB-500. The name points at GHK-Cu and its long history in skin research. The two repair peptides are included because they are the most studied compounds in soft tissue repair models, so the blend puts a skin-remodelling peptide and two tissue-repair peptides in one solution.
What Is KLOW Peptide?
KLOW is GLOW with a K for KPV. The KLOW blend holds the same 50 mg GHK-Cu, 10 mg BPC-157 and 10 mg TB-500, plus 10 mg of KPV, in an 80 mg vial. KPV is the tripeptide lysine-proline-valine, the final three amino acids of alpha-melanocyte-stimulating hormone (alpha-MSH). Research interest in it centres on inflammation.
So what are the KLOW peptide benefits in research terms? The blend adds an anti-inflammatory line of study to the repair and remodelling lines already in GLOW. Whether combining them produces anything beyond the sum of the parts has not been tested: we are not aware of any published study of either pre-mixed blend.
Why Each Component Is in the Blend
GHK-Cu
Maquart and colleagues (FEBS Letters, 1988) reported that GHK-Cu stimulated collagen synthesis in fibroblast cultures by about 80% at its peak concentration. Small topical trials reported improved skin density and wrinkle depth over 8 to 12 weeks. See our GHK-Cu explainer for the full background.
BPC-157
BPC-157 is a 15 amino acid sequence from a protein found in human gastric juice. Most of its literature comes from rodent models of tendon, ligament, muscle and gut injury, much of it from one research group in Zagreb. Controlled human data are sparse.
TB-500
TB-500 is a synthetic fragment of thymosin beta-4, a protein that binds actin and is involved in cell migration. The frequently cited wound study (Malinda et al., Journal of Investigative Dermatology, 1999) used full-length thymosin beta-4 in rats and reported re-epithelialisation 42% above saline controls at day 4 and up to 61% at day 7. The fragment and the full protein are not interchangeable, a point often lost in marketing.
KPV
Dalmasso and colleagues (Gastroenterology, 2008) reported that KPV is taken up into intestinal cells by the PepT1 transporter and, at nanomolar concentrations, reduced NF-kappaB inflammatory signalling and colitis severity in two mouse models.
Blend or Separate Vials?
This is the decision that matters more than GLOW vs KLOW. A blend saves vials, reconstitutions and paperwork: one vial, one lot, one certificate. But the ratio is fixed at 50:10:10 (plus 10 for KPV), you cannot measure any one component's effect in isolation, and you cannot change the proportion once it is mixed.
Our recommendation: use a blend only when your protocol already specifies that exact combination and ratio. For anything exploratory, separate vials are better science. The Radiance Bundle gives you GHK-Cu 50 mg, KPV 10 mg and BPC-157 10 mg as individual vials with bacteriostatic water and syringes, and TB-500 is available on its own as a 10 mg TB-500 vial. If you only want the two repair peptides without the copper peptide, the BPC-157 and TB-500 blend covers that. Our comparison of BPC-157 and TB-500 explains how those two differ.
Choosing Between the Glow Stack Peptides and KLOW
- Choose GLOW when the protocol uses GHK-Cu, BPC-157 and TB-500 at 50:10:10 and does not include KPV.
- Choose KLOW when the same protocol also calls for KPV at 10 mg per vial.
- Choose separate vials of GHK-Cu, KPV, BPC-157 and TB-500 when you need a different ratio or single-compound controls.
Whichever you pick, compare the label and the certificate, not just the name, because other suppliers sell different ratios under both. For concentration maths, the GHK-Cu calculator and the BPC-157 and TB-500 calculator work per component. Browse the full tissue repair peptide range for the individual compounds.
GLOW, KLOW and every component are sold by Chainwell Peptide for laboratory research use only, not for human or veterinary use.
Frequently asked questions
What is the difference between GLOW and KLOW?
+
KLOW contains everything in GLOW plus KPV. The Chainwell Peptide GLOW vial holds 50 mg GHK-Cu, 10 mg BPC-157 and 10 mg TB-500 (70 mg total). KLOW adds 10 mg KPV, an anti-inflammatory tripeptide from alpha-MSH, for 80 mg total. Every other component and amount is the same.
What is KLOW peptide?
+
KLOW is a pre-mixed research blend of four peptides in one freeze-dried vial: GHK-Cu, BPC-157, TB-500 and KPV. The Chainwell Peptide version is 80 mg, with 50 mg of GHK-Cu and 10 mg of each other component. The name is usually read as GLOW with a K added for KPV.
What is in glow stack peptides?
+
The glow stack combines GHK-Cu, BPC-157 and TB-500. In the Chainwell Peptide GLOW vial the amounts are 50 mg, 10 mg and 10 mg, for 70 mg in total. The powder is blue because GHK-Cu, which carries copper, makes up about 71% of the blend. Ratios vary between suppliers, so check the certificate.
What are the KLOW peptide benefits in research?
+
No published study has tested the KLOW blend itself. Its rationale comes from each component's own research: GHK-Cu in collagen synthesis, BPC-157 and TB-500 in rodent tissue repair models, and KPV in reducing inflammatory signalling in mouse colitis models. Any combined effect remains untested.
Is a blend better than separate vials?
+
Only when your protocol already uses that exact combination and ratio. A blend means one vial and one certificate, but the ratio is fixed and no component can be measured on its own. For exploratory work, separate vials, such as those in the Radiance Bundle, allow single-compound controls.





